Add like
Add dislike
Add to saved papers

Power of Three: Incremental Increase in the Ligand Field Strength of N-Alkylated 2,2'-Biimidazoles Leads to Spin Crossover in Homoleptic Tris-Chelated Fe(II) Complexes.

Homoleptic complexes [Fe(L n )]X2 (L1 = 1,1'-(α,α'- o-xylyl)-2,2'-biimidazole, L2 = 1,1'-(α,α'-3,4-dibromo- o-xylyl)-2,2'-biimidazole, L3 = 1,1'-(α,α'-2,5-dimethoxy- o-xylyl)-2,2'-biimidazole; X = BF4 - or ClO4 - ) were synthesized by direct reactions of the Fe(II) precursor salts and bidentate ligands L1 , L2 , or L3 . All mononuclear complexes undergo gradual temperature-driven spin-crossover (SCO) between the high-spin (HS, S = 2) and low-spin (LS, S = 0) states. Complexes with ligands L1 and L2 synthesized in methanol exhibit complete SCO with the midpoint of the LS↔HS conversion varying from 233 to 313 K, while complexes with ligand L3 , crystallized from an ethanol/dichloromethane mixture, exhibit incomplete SCO with the residual HS/LS ratio of ∼1:4 for [Fe(L3 )3 ](BF4 )2 and ∼1:1 for [Fe(L3 )3 ](ClO4 )2 . Complexes with L1 can also be recrystallized from ethanol/dichloromethane, in which case they exhibit very gradual and incomplete SCO, similar to those of the complexes with L3 . The differences in magnetic behavior have been traced back to peculiarities of molecular packing observed in the corresponding crystal structures. Density-functional theoretical calculations provide justification to the SCO behavior of these complexes, as compared to the HS-only behavior observed for the parent [Fe(bim)3 ]2+ complex with nonalkylated 2,2'-biimidazole (bim).

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

Managing Alcohol Withdrawal Syndrome.Annals of Emergency Medicine 2024 March 26

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app